Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer

被引:174
作者
Taylor, Matthew D. [1 ]
Nagji, Alykhan S. [1 ]
Bhamidipati, Castigliano M. [1 ]
Theodosakis, Nicholas [1 ]
Kozower, Benjamin D. [1 ]
Lau, Christine L. [1 ]
Jones, David R. [1 ]
机构
[1] Univ Virginia, Dept Surg, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; SURVIVAL; STAGE;
D O I
10.1016/j.athoracsur.2012.03.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Long-term survival after R0 resection for non-small cell lung cancer (NSCLC) is less than 50%. The majority of mortality after resection is related to tumor recurrence. The purpose of this study was to identify independent perioperative and pathologic variables that are associated with NSCLC recurrence after complete surgical resection. Methods. A retrospective examination was performed of a prospectively maintained database of patients who underwent resection for NSCLC from July 1999 to August 2008 at a single institution. Clinicopathologic variables were evaluated for their influence on time to recurrence. Cox's proportional regression hazard model examined the association of recurrence in NSCLC. Results. A total of 1,143 patients met inclusion criteria and had complete follow-up information. Of these patients, 378 (33.1%) had recurrence of the primary cancer. Median follow-up was 24 months (range, 3-134 months). Preoperative tumor maximum standardized uptake value (SUVmax) greater than 5 was associated with increased risk of recurrence (hazard ratio [HR], 1.81; p = 0.01). Preoperative radiation was independently associated with recurrence (HR, 1.98; p = 0.05) as well as the presence of pathologic stage II and stage III disease (stage II: HR, 2.53; p = 0.05; stage III: HR, 6.49; p = 0.006). Subgroup analysis found that sublobar resection was also associated with locoregional recurrence after resection (HR, 4.17; p = 0.02) and lymphovascular invasion of distant recurrence (HR, 4.21; p = 0.002). Conclusions. In the largest series reported to date on postresectional recurrence of NSCLC, SUVmax greater than 5, increasing pathologic stage, and the administration of preoperative radiation were independently associated with NSCLC recurrence after resection. Sublobar resection was independently associated with locoregional recurrence, and lymphovascular invasion was associated with distant recurrence. (Ann Thorac Surg 2012;93:1813-21) (c) 2012 by The Society of Thoracic Surgeons
引用
收藏
页码:1813 / 1821
页数:9
相关论文
共 50 条
[41]   Outcomes following resection of non-small cell lung cancer in octogenarians [J].
Vazirani, Jaideep ;
Moraes, Johanna ;
Barnett, Stephen ;
Johnson, Douglas F. ;
Knight, Simon ;
Miller, Alistair ;
Wright, Gavin ;
Alam, Naveed Z. ;
Conron, Matthew ;
Irving, Louis B. ;
Antippa, Phillip ;
Steinfort, Daniel P. .
ANZ JOURNAL OF SURGERY, 2018, 88 (12) :1322-1327
[42]   Resection in Stage I/II Non-Small Cell Lung Cancer [J].
Smolle-Juettner, F. M. ;
Maier, A. ;
Lindenmann, J. ;
Matzi, V. ;
Neuboeck, N. .
CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 :71-77
[43]   Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer [J].
Koike, Terumoto ;
Koike, Teruaki ;
Yoshiya, Katsuo ;
Tsuchida, Masanori ;
Toyabe, Shin-ichi .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (02) :372-378
[44]   Integrin alpha 2 is associated with tumor progression and postoperative recurrence in non-small cell lung cancer [J].
Matsumoto, Yoko ;
Kage, Hidenori ;
Morota, Mizuki ;
Zokumasu, Koichi ;
Ando, Takahiro ;
Maemura, Keita ;
Watanabe, Kousuke ;
Kawakami, Masanori ;
Hinata, Munetoshi ;
Ushiku, Tetsuo ;
Nakajima, Jun ;
Nagase, Takahide .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (01) :63-73
[45]   Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study [J].
Li, Zhao ;
Xu, Ke ;
Tartarone, Alfredo ;
Santarpia, Mariacarmela ;
Zhu, Yuming ;
Jiang, Gening .
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) :995-+
[46]   Age-related impairment of quality of life after lung resection for non-small cell lung cancer [J].
Schulte, Tobias ;
Schniewind, Bodo ;
Walter, Jessica ;
Dohrmann, Peter ;
Kuechler, Thomas ;
Kurdow, Roland .
LUNG CANCER, 2010, 68 (01) :115-120
[47]   Preoperative myosteatosis as a novel prognostic biomarker after anatomical lung resection for non-small cell lung cancer [J].
Sato, Seijiro ;
Nakayama, Saeko ;
Shinohara, Hirohiko .
SURGERY TODAY, 2025, 55 (06) :727-738
[48]   Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer [J].
Hirotsugu Kenmotsu ;
Yasuhisa Ohde ;
Kazushige Wakuda ;
Kazuhisa Nakashima ;
Shota Omori ;
Akira Ono ;
Tateaki Naito ;
Haruyasu Murakami ;
Hideaki Kojima ;
Shoji Takahashi ;
Mitsuhiro Isaka ;
Masahiro Endo ;
Toshiaki Takahashi .
Cancer Chemotherapy and Pharmacology, 2017, 80 :609-614
[49]   A clinical nomogram and heat map for assessing survival in patients with stage I non-small cell lung cancer after complete resection [J].
Cao, Xun ;
Zheng, Yu-zhen ;
Liao, Hong-ying ;
Guo, Xiang ;
Li, Yong ;
Wang, Zhen ;
Zhang, Li ;
Wang, Xu-dong ;
Wang, Xin .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[50]   Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer [J].
Kenmotsu, Hirotsugu ;
Ohde, Yasuhisa ;
Wakuda, Kazushige ;
Nakashima, Kazuhisa ;
Omori, Shota ;
Ono, Akira ;
Naito, Tateaki ;
Murakami, Haruyasu ;
Kojima, Hideaki ;
Takahashi, Shoji ;
Isaka, Mitsuhiro ;
Endo, Masahiro ;
Takahashi, Toshiaki .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) :609-614